Acquiring Company
Lupin
Acquired Company
VISUfarma B.V
Description
Lupin Limited has completed its acquisition of VISUfarma B.V., enhancing Lupin’s specialty care portfolio in ophthalmology. The acquisition includes over 60 branded products and expands Lupin's commercial footprint in key European markets. This strategic move is expected to accelerate the company's growth in the eye care sector.
Who to call at Lupin, and when
When Lupin changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Lupin raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lupin, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lupin. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lupin makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired VISUfarma B.V?
VISUfarma B.V was acquired by Lupin. The deal was reported on April 2, 2026. Lupin is a Mumbai-based pharma major dedicated to advancing medical science and improving patient lives globally. Lupin is privately held and operates in Biotechnology.
When did Lupin acquire VISUfarma B.V?
Lupin's acquisition of VISUfarma B.V was reported on April 2, 2026. Lupin Limited has completed its acquisition of VISUfarma B.V., enhancing Lupin’s specialty care portfolio in ophthalmology. The acquisition includes over 60 branded products and expands Lupin's commercial footprint in key European markets. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does VISUfarma B.V do?
VISUfarma B.V. is a portfolio company focused on ophthalmology, providing a broad range of innovative eye health products. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.